Ocular Therapeutix, Inc.: Revision history

20 August 2022

• curprev 11:1011:10, 20 August 2022 95.149.241.133 talk 1,852 bytes +11 No edit summary undo

13 August 2022

• curprev 16:3116:31, 13 August 2022 109.180.50.163 talk 1,841 bytes +15 No edit summary undo

8 August 2022

• curprev 03:4603:46, 8 August 2022 >Paris 1,826 bytes +1,826 Created page with "Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following oph..."